Data as of Dec 24
| -0.03 / -3.03%|
The 2 analysts offering 12-month price forecasts for Implant Sciences Corp have a median target of 1.38, with a high estimate of 1.75 and a low estimate of 1.00. The median estimate represents a +43.23% increase from the last price of 0.96.
The current consensus among 2 polled investment analysts is to Buy stock in Implant Sciences Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.